Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease (Q41160304)

27 September 2017

Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease (English)

1 reference

27 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Goran Šimić

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

4

Patrick R Hof

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

6

Peter Riederer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Melita Salkovic-Petrisic

7

object named as

Melita Salkovic-Petrisic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Jelena Osmanovic-Barilar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Marija Curlin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

26 March 2015

1 reference

Journal of Neural Transmission

27 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

577-592

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25808906%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00702-015-1394-4

7 June 2020

exact match

0 references

cites work

Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Evidence for lysosomal processing of amyloid beta-protein precursor in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

How does brain insulin resistance develop in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Brain metabolic dysfunction at the core of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Memory and mental status correlates of modified Braak staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Trafficking and proteolytic processing of APP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Tau protein diffuses along the microtubule lattice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Pathology and pathogenesis of vascular cognitive impairment-a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Transgenic mice as a model for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

A decade of modeling Alzheimer's disease in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Autophagy, amyloidogenesis and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Selection of appropriate reference genes for RT-qPCR analysis in a streptozotocin-induced Alzheimer's disease model of cynomolgus monkeys (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Sporadic dementia of Alzheimer's type induced by streptozotocin promotes anxiogenic behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Nitric oxide synthase does not mediate neurotoxicity after an i.c.v. injection of streptozotocin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Early and late neurodegeneration and memory disruption after intracerebroventricular streptozotocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Does Alzheimer's disease begin in the brainstem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Pyramidal neurons: dendritic structure and synaptic integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Two types of sporadic cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Silver diagnosis in neuropathology: principles, practice and revised interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-015-1394-4

Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose

21 January 2018

1 reference

12 December 2020

Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium

1 reference

12 December 2020

Early changes in neurons of the hippocampus and neocortex in transgenic rats expressing intracellular human a-beta.

1 reference

12 December 2020

Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid(1-42) peptide

1 reference

12 December 2020

Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats.

1 reference

12 December 2020

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

12 December 2020

Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein.

1 reference

12 December 2020

Amyloid-β secretion, generation, and lysosomal sequestration in response to proteasome inhibition: involvement of autophagy.

1 reference

12 December 2020

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach

1 reference

12 December 2020

Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys

1 reference

12 December 2020

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

1 reference

12 December 2020

The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas

1 reference

12 December 2020

Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease

1 reference

12 December 2020

Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta

1 reference

12 December 2020

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

1 reference

12 December 2020

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice

1 reference

12 December 2020

Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease.

1 reference

12 December 2020

Amyloid and Alzheimer's disease: inside and out.

1 reference

12 December 2020

Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin.

1 reference

12 December 2020

Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats.

1 reference

12 December 2020

Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein

1 reference

12 December 2020

Striatal dopaminergic D1 and D2 receptors after intracerebroventricular application of alloxan and streptozocin in rat

1 reference

12 December 2020